Theranica’s Nerivio Migra Wearable Gets FDA De Novo for Migraine Treatment

Nerivio Migra Migraine wearable
Theranica, a Netanya, Israel-based bio-medical technology company received FDA De Novo request for its smartphone-controlled wearable device Nerivio Migra®, which uses Remote Electrical Neuromodulation for acute migraine treatment. Migraine affects […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleMediaTek Launches New Multi-Mode 5G SoC to Power High-End 5G Devices
Next articleSolusGuard Launches Wearable Alarm to Protect Lone Workers
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)wearable-technologies.com.